News and Events
Most recent press releases. For a complete list, see here.
Topas Therapeutics and Boehringer Ingelheim Sign Multi-Year Collaboration and Option Agreement
Topas Therapeutics serves as exclusive translational partner for Collaborative Research Center focused on liver inflammation at University Medical Center Hamburg-Eppendorf
Topas Therapeutics extends its Series A to EUR 18 Million (USD 21 Million) with Boehringer Ingelheim Venture Fund
The next upcoming event. For a complete list, see here.